Squamous Cell Carcinoma

Although individuals in China with low-grade intraepithelial neoplasia are at higher risk for developing esophageal squamous cell carcinoma, that risk can be reduced by more than 30% with surveillance endoscopy, according to research.

More than half of patients had an objective response to first-line nivolumab for locally advanced or metastatic cutaneous squamous cell carcinoma, phase 2 study results published in Cancer showed.

Immunosuppression is not an independent risk factor for poor outcomes in patients with cutaneous squamous cell carcinomas when adjusting for tumor stage, according to a study.

Neoadjuvant cemiplimab induced a pathologic complete response among a majority of patients with resectable cutaneous squamous cell carcinoma, according to results of a nonrandomized phase 2 study presented at ESMO Congress.

FDA issued a safety alert Thursday regarding reports of squamous cell carcinoma and various lymphomas in the scar tissue surrounding breast implants.

A novel therapeutic approach targeting transforming growth factor-B1 and cyclooxygenase-2 demonstrated safety and efficacy in a small cohort of patients with cutaneous in situ squamous cell carcinoma, according to study findings.

Paclitaxel plus fluorouracil did not demonstrate OS superiority over paclitaxel plus cisplatin or paclitaxel plus carboplatin in definitive chemoradiation for locally advanced esophageal squamous cell carcinoma.

Poor differentiation and deep invasion are the most common risk factors for metastatic cutaneous squamous cell carcinoma following diameter and thickness, according to a study.

First-line treatment with nivolumab in patients with advanced esophageal squamous cell carcinoma resulted in longer overall survival compared with chemotherapy treatment alone, according to research.

Camrelizumab combined with apatinib may potentially be used as a second-line treatment for advanced esophageal squamous cell carcinoma, according to phase 2 results published in The Lancet Gastroenterology & Hepatology.